NPAT in 2016 was $6.4m but that included $3.8m depreciation versus $5.8m investing cash outflows which are mostly for software development. I prefer to include these in my profit figure given they are a cost of doing business for software companies. Therefore, normalised profit for 2016 was <$5m in line with FCF.
For forward PE to be under 30 you are saying that FCF this year will be >$15m - I would be very surprised.
Even if you are right, I'd still question the logic of buying back stock at 30x earnings. Then again, they have a better idea of the value of the business than me but it would have to be a business of extremely rare quality for this to be justified.
- Forums
- ASX - By Stock
- PME
- Ann: Daily share buy-back notice - Appendix 3E
PME
pro medicus limited
Add to My Watchlist
1.60%
!
$323.01

Ann: Daily share buy-back notice - Appendix 3E, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$323.01 |
Change
-5.245(1.60%) |
Mkt cap ! $33.74B |
Open | High | Low | Value | Volume |
$323.50 | $327.58 | $318.07 | $21.77M | 67.54K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 10 | $322.99 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$323.02 | 5 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 8 | 322.850 |
1 | 4 | 322.840 |
1 | 4 | 322.830 |
1 | 2 | 322.820 |
1 | 10 | 322.800 |
Price($) | Vol. | No. |
---|---|---|
322.900 | 2 | 1 |
322.940 | 2 | 1 |
322.950 | 20 | 5 |
322.960 | 5 | 2 |
322.980 | 106 | 3 |
Last trade - 14.55pm 23/07/2025 (20 minute delay) ? |
Featured News
PME (ASX) Chart |